The HudsonAlpha Institute for Biotechnology (www.hudsonalpha.org) is a non-profit organization with the mission to use biotechnology and basic biological research to make important discoveries, improve human health, stimulate economic development, inspire young people to seek careers in science and teach members of the public the importance of science in their everyday lives. Located in Cummings Research Park in Huntsville, Alabama, one of the world's leading science and technology parks, HudsonAlpha's campus contains state-of-the-art laboratories for biological research and development, as well as education, in the areas of genomics, genetics and personalized medicine.
The Clinical Services Laboratory at the HudsonAlpha Institute for Biotechnology utilizes genomic information in the diagnosis of patients with cancer and genetic disorders. The laboratory carries out whole genome sequencing utilizes cutting-edge next-generation sequencing (NGS) technology and analysis software in a CLIA/CAP certified laboratory to provide physicians and their patients with comprehensive genomic analysis and reporting. Additionally, the laboratory performs more focused testing utilizing other advanced genomics technologies to assess human health and disease.
The Clinical Services Laboratory of The HudsonAlpha Institute for Biotechnology seeks a highly motivated, detail-oriented associate director for the clinical genomics program to lead the expansion of the laboratory's high-volume testing. This position offers a unique opportunity to work closely with a team of molecular and clinical geneticists, genetic counselors, and bioinformaticians to develop high-volume testing utilizing Ilumina NovaSeq, microarray and other technologies in the settings of cancer and rare diseases diagnostics and population screening.
In conjunction with the Director of the Clinical Services Laboratory, the Associate Director assumes responsibility for the clinical activities of the Clinical Services Laboratory. The primary responsibilities focus on high throughput testing, coordinating the teams tasked with testing, informatics, production management and production planning. This individual will work closely with the research and development team to bring new assays into CAP/CLIA compliant production using a variety of molecular genetics platforms. The Associate Director will be one of several directors to review/sign out of clinical cases and communicate with referring providers.
The successful candidate will have a PhD, MD/PhD, or MD (US Medical License not required) and must be certified or eligible for certification by the American Board of Medical Genetics and Genomics in Clinical Molecular Diagnostics or certification by the American Board of Pathology with specialty training in molecular genetics. Fundamental knowledge of human genetics and medical genetics is essential. Expertise in pertinent areas of high-volume testing, clinical molecular genetic testing in both cancer and rare disease, NGS analysis and online human genomics resources is key. Excellent time management and communication skills are important.
JOB SPECIFIC TASKS
Coordinate and expand high throughput molecular genetic testing
Analyze, review and sign out of results of genomic testing
Provide clinical and technical support to referring providers
Develop new clinical molecular assays
Maintain CAP/CLIA certification
Education and Experience:
MD, Ph.D. or both
ACMG certification or ABP certification
Experience in high volume molecular testing
Strongly Preferred Skills:
Experience with molecular testing for rare diseases and cancer
Understanding of NGS technology and related molecular technologies
Strong understanding of human and medical genetics
Knowledge of CLIA and CAP regulations
Telecommuting is allowed.
Internal Number: 1803316
About HudsonAlpha Clinical Services Lab, LLC
The HudsonAlpha Clinical Services Lab team works to solve undiagnosed diseases and end diagnostic odysseys. Our goal is to provide support that goes beyond the genome, helping resolve uncertainty and seeking answers for symptoms that remain unexplained by DNA sequencing.